Conditional mouse models with dominant negative Osteogenesis Imperfecta

显性负性成骨不全的条件小鼠模型

基本信息

  • 批准号:
    10646852
  • 负责人:
  • 金额:
    $ 23.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

The goal of this R21 application is to convert existing mouse models of moderate and severe Osteogenesis Imperfecta (OI) caused by type 1 collagen mutations to conditional mouse models of moderate and severe OI. Conditional mouse models offer several advantages over the existing strains. First, conditional mouse strains can be maintained and distributed by public repositories; existing strains are in individual labs, and not in repositories, because of their skeletal fragility. Second, OI is a multi-system disease that affects bone, heart, lung, tendon, ligament, and skin. When studying OI, the phenotype in one organ system (e.g., heart or lung) is confounded by disease-associated problems in another organ system (e.g., spine and ribs). Conditional mouse models in which Cre-recombinase is used to express the mutant protein in a tissue-specific manner minimizes this confounding. Currently, there are no conditional mouse models with type 1 collagen mutations, even though ~ 85% of human OI is caused by such mutations. Third, by converting existing strains to conditional strains, any new data obtained with the conditional strains can be compared to previously published data because the same mutation was studied. We will modify existing alleles by inserting a gene-trap using i- GONAD gene-editing technology. Applying gene-traps and i-GONAD will enable us to efficiently convert 4 existing OI-causing alleles (Aga2, Jrt, Brtl, and p.G610C) in mice to conditional OI-causing alleles. Mouse strains with the new conditional alleles can be distributed by public repositories. We will also determine the effect of inducing endogenous expression of mutant type 1 collagen in hypertrophic chondrocytes, since hypertrophic chondrocytes have been shown to transdifferentiate into osteoblasts and osteoprogenitors. Therefore, it is important to know if bone properties are strongly influenced by cells expressing mutant type 1 collagen that have descended from hypertrophic chondrocytes, or if unaffected bone forming cells descended from other progenitor sources compensate for, or outcompete, the mutant hypertrophic chondrocyte-derived descendants. This latter knowledge will aid investigators who are interested in using cell therapies to displace/replace mutant osteoblasts and osteoprogenitors with wild-type ones.
这项R21应用的目标是将现有的中度和重度成骨小鼠模型 将由1型胶原突变引起的不完全性(OI)转化为中度和重度OI的条件性小鼠模型。 条件小鼠模型提供了几个优于现有品系的优点。第一,条件小鼠品系 可以由公共储存库维护和分发;现有的菌株在各个实验室,而不是在 因为它们的骨骼脆弱。其次,OI是一种多系统疾病,影响骨骼,心脏, 肺、肌腱、韧带和皮肤。当研究OI时,一个器官系统中的表型(例如,心脏或肺)是 被另一器官系统中的疾病相关问题混淆(例如,脊柱和肋骨)。条件性小鼠 其中Cre重组酶用于以组织特异性方式表达突变蛋白的模型最小化了 这混乱。目前,还没有1型胶原蛋白突变的条件性小鼠模型,甚至 尽管约85%的人类OI是由这种突变引起的。第三,通过将现有菌株转化为有条件的 菌株,用条件菌株获得的任何新数据都可以与先前公布的数据进行比较 因为研究的是相同的突变我们将修改现有的等位基因插入基因陷阱使用i- GONAD基因编辑技术应用基因陷阱和i-GONAD将使我们能够有效地转化4 将小鼠中现有的引起OI的等位基因(Aga 2、Jrt、Brtl和p.G610C)转化为条件性引起OI的等位基因。鼠标 具有新的条件等位基因的菌株可以由公共储存库分发。我们还将确定 诱导肥大软骨细胞中突变型1型胶原内源性表达的作用, 已经显示肥大软骨细胞转分化成成骨细胞和骨祖细胞。 因此,重要的是要知道,如果骨性能受到强烈影响的细胞表达突变型1 胶原蛋白来自肥大的软骨细胞,或者如果未受影响的骨形成细胞 来自其他祖细胞来源的突变肥大软骨细胞来源的细胞补偿或胜过突变肥大软骨细胞来源的细胞。 后裔后一种知识将有助于对使用细胞疗法感兴趣的研究人员, 用野生型替代/替换突变型成骨细胞和骨祖细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew L Warman其他文献

Directed differentiation of human pluripotent stem cells into articular cartilage reveals effects caused by absence of emWISP3/em, the gene responsible for progressive pseudorheumatoid arthropathy of childhood
人多能干细胞向关节软骨的定向分化揭示了由于缺乏 emWISP3/em(负责儿童进行性假类风湿性关节炎的基因)而引起的影响
  • DOI:
    10.1136/ard-2023-224304
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    20.600
  • 作者:
    Chaochang Li;Mireia Alemany-Ribes;Rosanne M Raftery;Uzochi Nwoko;Matthew L Warman;April M Craft
  • 通讯作者:
    April M Craft

Matthew L Warman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew L Warman', 18)}}的其他基金

Skeletal and non-skeletal roles for osteocalcin
骨钙素的骨骼和非骨骼作用
  • 批准号:
    10417887
  • 财政年份:
    2022
  • 资助金额:
    $ 23.36万
  • 项目类别:
Skeletal and non-skeletal roles for osteocalcin
骨钙素的骨骼和非骨骼作用
  • 批准号:
    10595042
  • 财政年份:
    2022
  • 资助金额:
    $ 23.36万
  • 项目类别:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
成骨不全小鼠模型的神经行为表型
  • 批准号:
    10416072
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
成骨不全小鼠模型的神经行为表型
  • 批准号:
    10303525
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
The Efficacy of combination therapy in Osteogenesis Imperfecta
联合治疗成骨不全症的疗效
  • 批准号:
    8900679
  • 财政年份:
    2015
  • 资助金额:
    $ 23.36万
  • 项目类别:
Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study
从研究中获得的骨骼生物学机制和治疗见解
  • 批准号:
    8720467
  • 财政年份:
    2014
  • 资助金额:
    $ 23.36万
  • 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
  • 批准号:
    9052710
  • 财政年份:
    2014
  • 资助金额:
    $ 23.36万
  • 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
  • 批准号:
    8830919
  • 财政年份:
    2014
  • 资助金额:
    $ 23.36万
  • 项目类别:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
骨骼系统非遗传性遗传疾病:发病机制和治疗
  • 批准号:
    9245631
  • 财政年份:
    2014
  • 资助金额:
    $ 23.36万
  • 项目类别:
Does increasing bone mass also increase bone strength in mouse models of OI?
增加骨量是否也会增加成骨不全小鼠模型的骨强度?
  • 批准号:
    8232602
  • 财政年份:
    2011
  • 资助金额:
    $ 23.36万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 23.36万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 23.36万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 23.36万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 23.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 23.36万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 23.36万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 23.36万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 23.36万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 23.36万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了